These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32884613)

  • 21. In vitro antimicrobial susceptibility patterns of Propionibacterium acnes isolated from patients with acne vulgaris.
    Biswal I; Gaind R; Kumar N; Mohanty S; Manchanda V; Khunger N; V R; Deb M
    J Infect Dev Ctries; 2016 Oct; 10(10):1140-1145. PubMed ID: 27801379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore.
    Tan HH; Goh CL; Yeo MG; Tan ML
    Ann Acad Med Singap; 2001 Jan; 30(1):22-5. PubMed ID: 11242619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilizing the photodynamic properties of curcumin to disrupt biofilms in Cutibacterium acnes: A promising approach for treating acne.
    Zheng N; Xie Y; Zhou M; Liu Y; Xu H; Zeng R; Wan C; Li M
    Photodiagnosis Photodyn Ther; 2024 Feb; 45():103928. PubMed ID: 38070633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug Resistance Plasmid pTZC1 Could Be Pooled among
    Koizumi J; Nakase K; Hayashi N; Takeo C; Nakaminami H
    Microbiol Spectr; 2023 Feb; 11(2):e0362822. PubMed ID: 36847559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibacterial Susceptibility Testing of
    Skadins I; Zavorins A; Kroica J; Pavloviča T; Bruzgule D; Averjanova T
    Clin Cosmet Investig Dermatol; 2021; 14():671-677. PubMed ID: 34168479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility profiles of Propionibacterium acnes isolated from patients with acne vulgaris.
    Grech I
    J Glob Antimicrob Resist; 2014 Mar; 2(1):35-38. PubMed ID: 27873635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm.
    Oprica C; Emtestam L; Lapins J; Borglund E; Nyberg F; Stenlund K; Lundeberg L; Sillerström E; Nord CE
    Anaerobe; 2004 Jun; 10(3):155-64. PubMed ID: 16701513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiomes in Acne Vulgaris and Their Susceptibility to Antibiotics in Indonesia: A Systematic Review and Meta-Analysis.
    Legiawati L; Halim PA; Fitriani M; Hikmahrachim HG; Lim HW
    Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of Cutibacterium acnes to topical minocycline foam.
    Sutcliffe J; McLaughlin R; Webster G; Read AF; Drlica K; Elliott R; Stuart I
    Anaerobe; 2020 Apr; 62():102169. PubMed ID: 32058277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
    Sadhasivam S; Sinha M; Saini S; Kaur SP; Gupta T; Sengupta S; Ghosh S; Sardana K
    Dermatol Ther; 2016 Nov; 29(6):451-454. PubMed ID: 27424878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance of propionibacteria to antibiotics used in the treatment of acne.
    Brown JM; Poston SM
    J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.
    Alexis A; Del Rosso JQ; Desai SR; Downie JB; Draelos ZD; Feser C; Forconi R; Fowler JF; Gold M; Kaufman-Janette J; Lain E; Lee M; Ling M; Shamban AT; Werschler WP; Daniels A
    J Clin Aesthet Dermatol; 2018 Nov; 11(11):25-35. PubMed ID: 30588271
    [No Abstract]   [Full Text] [Related]  

  • 33. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
    Aoki S; Nakase K; Hayashi N; Noguchi N
    J Med Microbiol; 2019 Jan; 68(1):26-30. PubMed ID: 30431414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong.
    Luk NM; Hui M; Lee HC; Fu LH; Liu ZH; Lam LY; Eastel M; Chan YK; Tang LS; Cheng TS; Siu FY; Ng SC; Lai YK; Ho KM
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating
    Yu R; Yu L; Ning X; Cui Y
    Front Microbiol; 2024; 15():1424849. PubMed ID: 38974030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic antibiotic therapy of acne vulgaris.
    Ochsendorf F
    J Dtsch Dermatol Ges; 2006 Oct; 4(10):828-41. PubMed ID: 17010172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan.
    Nakase K; Nakaminami H; Takenaka Y; Hayashi N; Kawashima M; Noguchi N
    J Med Microbiol; 2014 May; 63(Pt 5):721-728. PubMed ID: 24523159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter cross-sectional observational study of antibiotic resistance and the genotypes of Propionibacterium acnes isolated from Chinese patients with acne vulgaris.
    Fan Y; Hao F; Wang W; Lu Y; He L; Wang G; Chen W
    J Dermatol; 2016 Apr; 43(4):406-13. PubMed ID: 26508505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staphylococcus aureus carriage rates and antibiotic resistance patterns in patients with acne vulgaris.
    Delost GR; Delost ME; Armile J; Lloyd J
    J Am Acad Dermatol; 2016 Apr; 74(4):673-8. PubMed ID: 26777099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
    Zhanel G; Critchley I; Lin LY; Alvandi N
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.